EverSource Wealth Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$357K Sell
4,459
-459
-9% -$37.8K 0.01% 761
2025
Q4
$419K Buy
4,918
+508
+12% +$41.7K 0.02% 604
2025
Q3
$343K Buy
4,410
+1,230
+39% +$96.1K 0.01% 664
2025
Q2
$249K Buy
3,180
+959
+43% +$71.5K 0.01% 767
2025
Q1
$161K Buy
2,221
+917
+70% +$65.6K 0.01% 740
2024
Q4
$96.5K Buy
1,304
+282
+28% +$19.7K 0.01% 911
2024
Q3
$67.4K Buy
1,022
+90
+10% +$6.54K ﹤0.01% 934
2024
Q2
$58.8K Buy
932
+280
+43% +$24.8K ﹤0.01% 1013
2024
Q1
$55.2K Sell
652
-846
-56% -$71.1K ﹤0.01% 939
2023
Q4
$114K Sell
1,498
-416
-22% -$28.9K 0.01% 591
2023
Q3
$133K Sell
1,914
-1,496
-44% -$120K 0.01% 487
2023
Q2
$322K Sell
3,410
-12
-0.4% -$1.04K 0.04% 293
2023
Q1
$283K Buy
3,422
+31
+0.9% +$2.44K 0.04% 314
2022
Q4
$253K Buy
3,391
+1,782
+111% +$137K 0.04% 316
2022
Q3
$133K Sell
1,609
-5
-0.3% -$481 0.03% 362
2022
Q2
$154K Buy
1,614
+629
+64% +$65.1K 0.04% 291
2022
Q1
$116K Buy
985
+761
+340% +$85.4K 0.03% 312
2021
Q4
$29K Buy
+224
New +$26.1K 0.01% 544

Other funds holding EW

EverSource Wealth Advisors's EW Position: Q1 2026 in Review

EverSource Wealth Advisors reduced its Edwards Lifesciences (EW) stake by 9.3% in Q1 2026, selling an estimated $37.8K and leaving 4,459 shares worth $357K. The position accounts for 0.01% of the portfolio, ranked #761.

EverSource Wealth Advisors first reported a position in EW in Q4 2021 and has held it in 18 quarters since. The position peaked at $419K in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • EverSource Wealth Advisors held 4,459 shares of Edwards Lifesciences worth $357K as of Q1 2026.
  • EverSource Wealth Advisors sold 459 Edwards Lifesciences shares in Q1 2026, an estimated $37.8K.
  • Edwards Lifesciences made up 0.01% of EverSource Wealth Advisors's portfolio in Q1 2026, its #761 holding.
  • EverSource Wealth Advisors first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 18 quarters since.
  • EverSource Wealth Advisors's Edwards Lifesciences position peaked at $419K in Q4 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.